Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy

• Autori principali: Weijie Cao (Autore), Haizhou Xing (Autore), Yingmei Li (Autore), Wenliang Tian (Autore), Yongping Song (Autore), Zhongxing Jiang (Autore), Jifeng Yu (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2022-05-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract The claudin18.2 (CLDN18.2) protein, an isoform of claudin18, a member of the tight junction protein family, is a highly selective biomarker with limited expression in normal tissues and often abnormal expression during the occurrence and development of various primary malignant tumors, such...